News from Translational Psychiatry 15 November 2011: Video gamers and Tourette's therapy

This press release contains:

---Summaries of newsworthy papers:

Brain’s reward system may be altered in excessive video-game players

Less intrusive therapy for Tourette’s Syndrome

A PDF of the paper mentioned on this release can be found in the Academic journals section of http://press.nature.com. Press contacts are listed at the end of this release.

------------------------------------------------------------------------------------------

Brain’s reward system may be altered in excessive video-game players
DOI: 10.1038/TP.2011.53

The structure and activity in a part of the brain associated with reward processing is altered in frequent video-game players, according to research published online in this week’s Translational Psychiatry. These results suggest that rewarding stimuli are processed differently in frequent gamers.

The dopamine-related ventral striatum, a structure of the brain’s reward system, has been implicated in gaming and computer gambling in previous studies; however, structural brain correlates of videogame playing have not been investigated. Analyzing MRI scans of 154 14-year-olds, Simone Kühn, Jürgen Gallinat and colleagues find that frequent gamers have higher left striatal grey matter volume compared to moderate gamers. In addition, frequent gamers display enhanced functional MRI activity overlapping with the high-volume grey matter region when not winning in a gambling task.

The observed volumetric differences in ventral striatum could likewise be a precondition rather than consequence of frequent gaming. Thus, individuals with higher ventral striatal volume might experience video-gaming as more rewarding than those with lower ventral striatal volume, facilitating skill acquisition and leading to further reward. These findings demonstrate that the ventral striatum plays a significant role in excessive video-game playing and contributes to our understanding of behavioral addiction.

Author contacts:

Simone Kühn (University of Ghent, Belgium)
E-mail: [email protected]

Jürgen Gallinat (Charité University Medicine, Berlin, Germany)
Tel: +49 30 2311 2904; E-mail: [email protected]

Editorial contact:

Julio Licinio (The Australian National University, Canberra, Australia)
Tel: +61 2 6125 2550; E-mail: [email protected]

------------------------------------------------------------------------------------

Less intrusive therapy for Tourette’s Syndrome
DOI: 10.1038/TP.2011.51

Deep brain stimulation to just one hemisphere of two patients with Tourette’s Syndrome proved effective by significantly diminishing their repetitive symptoms, reports a study published this week in Translational Psychiatry. Though this kind of stimulation to both sides of the brain has been shown to reduce tics and repetitive symptoms of Tourette’s, this is the first time that unilateral stimulation has been shown to be just as effective.

For over a decade, deep brain stimulation has been therapeutically used to reduce Tourette’s symptoms in patients who have not been helped by medication or other forms of therapy. By stimulating the thalamus—important in motor function—as well as other areas on both sides of the brain, tic frequency and severity can be reduced, though there is concern about the intrusiveness of such a surgery.

Jens Kuhn and colleagues show the unilateral thalamic stimulation is just as effective in two patients, while being less invasive. One year after the deep brain stimulation, one patient had a 100% symptom reduction, and the other a 63% symptom reduction, with similar improvements in motor and vocal tics. Next to its potential benefits on motor and vocal tics, Kuhn and colleagues discuss the ethical implications of the intervention, including positive effects on mood and global functioning but also less desirable cognitive side effect.

Author contact:

Jens Kuhn (University of Cologne, Germany)
Tel: +49 221 478 4005; E-mail: [email protected]

Editorial contact:

Julio Licinio (The Australian National University, Canberra, Australia)
Tel: +61 2 6125 2550; E-mail: [email protected]

------------------------------------------------------------------------------------

PRESS CONTACTS…

From North America and Canada

Neda Afsarmanesh, Nature New York
Tel: +1 212 726 9231; E-mail: [email protected]

From Japan, Korea, China, Singapore and Taiwan

Mika Nakano, Nature Tokyo
Tel: +81 3 3267 8751; E-mail: [email protected]

From the UK

Rebecca Walton, Nature, London
Tel: +44 20 7843 4502; E-mail: [email protected]

---------------------------------------------------------------------------------------

About Nature Publishing Group (NPG):

Nature Publishing Group (NPG) is a publisher of high impact scientific and medical information in print and online. NPG publishes journals, online databases and services across the life, physical, chemical and applied sciences and clinical medicine.

Focusing on the needs of scientists, Nature (founded in 1869) is the leading weekly, international scientific journal. In addition, for this audience, NPG publishes a range of Nature research journals and Nature Reviews journals, plus a range of prestigious academic journals including society-owned publications. Online, nature.com provides over 5 million visitors per month with access to NPG publications and online databases and services, including Nature News and NatureJobs plus access to Nature Network and Nature Education’s Scitable.com.

Scientific American is at the heart of NPG’s newly-formed consumer media division, meeting the needs of the general public. Founded in 1845, Scientific American is the oldest continuously published magazine in the US and the leading authoritative publication for science in the general media. Together with scientificamerican.com and 15 local language editions around the world it reaches over 3 million consumers and scientists. Other titles include Scientific American Mind and Spektrum der Wissenschaft in Germany.

Throughout all its businesses NPG is dedicated to serving the scientific and medical communities and the wider scientifically interested general public. Part of Macmillan Publishers Limited, NPG is a global company with principal offices in London, New York and Tokyo, and offices in cities worldwide including Boston, Buenos Aires, Delhi, Hong Kong, Madrid, Barcelona, Munich, Heidelberg, Basingstoke, Melbourne, Paris, San Francisco, Seoul and Washington DC. For more information, please go to www.nature.com.